Würdinger Thomas, Tannous Bakhos A, Saydam Okay, Skog Johan, Grau Stephan, Soutschek Jürgen, Weissleder Ralph, Breakefield Xandra O, Krichevsky Anna M
Department of Neurology, Massachusetts General Hospital and Neuroscience Program, Harvard Medical School, Boston, MA 02115, USA.
Cancer Cell. 2008 Nov 4;14(5):382-93. doi: 10.1016/j.ccr.2008.10.005.
A key step in angiogenesis is the upregulation of growth factor receptors on endothelial cells. Here, we demonstrate that a small regulatory microRNA, miR-296, has a major role in this process. Glioma cells and angiogenic growth factors elevate the level of miR-296 in primary human brain microvascular endothelial cells in culture. The miR-296 level is also elevated in primary tumor endothelial cells isolated from human brain tumors compared to normal brain endothelial cells. Growth factor-induced miR-296 contributes significantly to angiogenesis by directly targeting the hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) mRNA, leading to decreased levels of HGS and thereby reducing HGS-mediated degradation of the growth factor receptors VEGFR2 and PDGFRbeta. Furthermore, inhibition of miR-296 with antagomirs reduces angiogenesis in tumor xenografts in vivo.
血管生成的一个关键步骤是内皮细胞上生长因子受体的上调。在此,我们证明一种小的调节性微小RNA,即miR-296,在这一过程中起主要作用。胶质瘤细胞和血管生成生长因子可提高培养的原代人脑微血管内皮细胞中miR-296的水平。与正常脑内皮细胞相比,从人脑肿瘤中分离出的原代肿瘤内皮细胞中miR-296水平也升高。生长因子诱导的miR-296通过直接靶向肝细胞生长因子调节的酪氨酸激酶底物(HGS)mRNA,对血管生成有显著贡献,导致HGS水平降低,从而减少HGS介导的生长因子受体VEGFR2和PDGFRβ的降解。此外,用抗miR-296抑制物抑制miR-296可减少体内肿瘤异种移植中的血管生成。